Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
In light of the recent observance of World Obesity Day on March 4, 2024, we aim to raise awareness about this matter and discuss some of the issues linked to medications for treatment of obesity
The second hard truth: 'eyeballing' doses on a syringe without converting milliliters to units first is how contamination and dosing errors compound
Researchers say it may also offer clues about whether GLP-1 medications could eventually be used to address other problems involving reward and craving, including substance use disorder
Editors note This story was produced in partnership with the Department of Journalism and Media Communication as part of a special class in which students get hands-on experiences developing and producing content with the Division of Marketing and Communications for SOURCE, the news website of CSU
To qualify, you need to meet one of the following requirements when starting GLP-1 treatment: A BMI (body mass index) of 35 or higher A BMI between 30 and 34.99, with one or more additional conditions: Diastolic heart failure Uncontrolled high blood pressure/hypertension Chronic kidney disease, stage 3a or higher Prediabetes Previous heart attack or stroke Blocked arteries in arms or legs with symptoms A BMI between 27 and 29.99, with one or more additional conditions: Prediabetes Previous heart attack or stroke Blocked arteries in arms or legs with symptoms Medicare beneficiaries who have sleep apnea, diabetes or fatty liver disease cant access the program, but their Medicare Part D insurance might cover their GLP-1s separately based on those diagnoses
)
